5-methylcytosine has been researched along with Neuroendocrine Tumors in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Hart, J; Keutgen, XM; Krausz, T; Olivas, A; Parilla, M; Setia, N; Sharma, AE; Wang, H; Weber, C; Yassan, L; Zhang, SS | 1 |
Butz, H; Czirják, S; Karászi, K; Krencz, I; Krokker, L; Mészáros, K; Németh, K; Patócs, A; Rajnai, H; Reiniger, L; Szabó, B; Szücs, N | 1 |
Barazeghi, E; Hellman, P; Norlén, O; Prabhawa, S; Stålberg, P; Westin, G | 1 |
3 other study(ies) available for 5-methylcytosine and Neuroendocrine Tumors
Article | Year |
---|---|
Epigenetic Dysregulation of 5-hydroxymethylcytosine in Well-Differentiated Pancreatic Neuroendocrine Tumors.
Topics: 5-Methylcytosine; Epigenesis, Genetic; Female; Humans; Mitotic Index; Neuroendocrine Tumors; Pancreatic Neoplasms | 2022 |
Demethylation Status of Somatic DNA Extracted From Pituitary Neuroendocrine Tumors Indicates Proliferative Behavior.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Case-Control Studies; Cell Proliferation; Dioxygenases; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; DNA-Binding Proteins; DNA, Neoplasm; Epigenesis, Genetic; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pituitary Neoplasms; Prognosis; Proto-Oncogene Proteins; Ubiquitin-Protein Ligases; Young Adult | 2020 |
Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors.
Topics: 5-Methylcytosine; Adult; Aged; Cell Nucleus; Dioxygenases; DNA-Binding Proteins; Humans; Intestinal Neoplasms; Intestine, Small; Middle Aged; Mixed Function Oxygenases; Neuroendocrine Tumors; Proto-Oncogene Proteins | 2018 |